65--Dipeptidyl-Peptidase 4(DPP-4) Inhibitors

Page 2 of 2 PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79719R0035 for an unrestrictive procurement for Dipeptidyl-Peptidase 4(DPP-4) Inhibitors for the Department of Veterans Affairs (VA). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79719R0035 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 16, 2019, with a tentative closing date of October 31, 2019. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to:  [email protected]. Estimated annual quantities are as follows: ITEM DESCRIPTION PKG SIZE TOTAL EST ANNUAL USAGE (Tablets) 1 Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors *class includes the following: -Alogliptin -Linagliptin -Saxagliptin -Sitagliptin Prices shall be submitted on a per tablet basis, at the same price per tablet for all strengths (Flat Price). All package sizes and strengths are accepted. 41,982,917